Talphera (TLPH) Cash from Investing Activities (2010 - 2026)

Talphera's (TLPH) quarterly Cash from Investing Activities came in at -$2.7 million in Q1 2026, down 178.21% quarter-over-quarter from $3.5 million in Q4 2025.

Talphera (TLPH) Cash from Investing Activities (2010 - 2026) Analysis & Trends

Talphera's Cash from Investing Activities history runs 17 years deep, the most recent figure standing at -$2.7 million for Q1 2026.

  • On a quarterly basis, Cash from Investing Activities changed N/A year-over-year to -$2.7 million in Q1 2026; TTM through Mar 2026 was -$17.1 million, a 362.0% decrease from a year earlier, with the FY2025 full-year figure at -$14.3 million, down 479.4% from the prior year.
  • Cash from Investing Activities fell to -$2.7 million in Q1 2026 per TLPH's latest filing, from $3.5 million in the prior quarter.
  • Across five years, Cash from Investing Activities topped out at $20.2 million in Q1 2022 and bottomed at -$17.8 million in Q3 2025.
  • The 5-year median for Cash from Investing Activities is $2.7 million (2022), against an average of $1.7 million.
  • Across the five-year window, Cash from Investing Activities jumped 283.28% in 2022 and slumped 3069.17% in 2025, its largest moves.
  • Year by year, Cash from Investing Activities stood at $2.7 million in 2022, then sank by 237.26% to -$3.7 million in 2023, then soared by 116.43% to $600000.0 in 2024, then jumped by 478.33% to $3.5 million in 2025, then sank by 178.21% to -$2.7 million in 2026.
  • Per Business Quant, the three latest TLPH Cash from Investing Activities figures stand at -$2.7 million (Q1 2026), $3.5 million (Q4 2025), and -$17.8 million (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Haleon 89.42 Bn 87.55 Bn - -
2 Teva Pharmaceutical Industries 35.92 Bn 32.18 Bn 1.97 Bn 229.00 Mn
3 Zoetis 32.68 Bn 30.74 Bn 1.62 Bn -87.00 Mn
4 Takeda Pharmaceutical 27.63 Bn 23.57 Bn 4.39 Bn -369.95 Mn
5 United Therapeutics 23.16 Bn 21.01 Bn 648.10 Mn 743.70 Mn
6 RedHill Biopharma 21.80 Bn 21.80 Bn - -
7 Viatris 20.34 Bn 18.54 Bn 1.16 Bn 277.40 Mn
8 Neurocrine Biosciences 17.79 Bn 16.47 Bn 800.70 Mn -506.20 Mn
9 Elanco Animal Health 12.65 Bn 12.22 Bn 785.00 Mn -60.00 Mn
10 Talphera 90.77 Mn 90.77 Mn - -2.71 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -2.71 Mn
Mar 31, 2026 -2.71 Mn
Dec 31, 2025 3.47 Mn
Dec 31, 2025 3.47 Mn
Sep 30, 2025 -17.82 Mn
Sep 30, 2025 -17.82 Mn
Sep 30, 2024 600,000.00
Sep 30, 2024 600,000.00
Jun 30, 2024 5.91 Mn
Jun 30, 2024 5.91 Mn
Mar 31, 2024 -2.73 Mn
Mar 31, 2024 -2.73 Mn
Dec 31, 2023 -3.65 Mn
Dec 31, 2023 -3.65 Mn
Jun 30, 2023 2.72 Mn
Jun 30, 2023 2.72 Mn
Mar 31, 2023 400,000.00
Mar 31, 2023 400,000.00
Dec 31, 2022 2.66 Mn
Dec 31, 2022 2.66 Mn